Literature DB >> 27402173

Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.

Sheraz Khoja1, Vivek Shah2, Damaris Garcia2, Liana Asatryan3, Michael W Jakowec2, Daryl L Davies4.   

Abstract

Purinergic P2X4 receptors (P2X4Rs) belong to the P2X superfamily of ion channels regulated by ATP. We recently demonstrated that P2X4R knockout (KO) mice exhibited deficits in sensorimotor gating, social interaction, and ethanol drinking behavior. Dopamine (DA) dysfunction may underlie these behavioral changes, but there is no direct evidence for P2X4Rs' role in DA neurotransmission. To test this hypothesis, we measured markers of DA function and dependent behaviors in P2X4R KO mice. P2X4R KO mice exhibited altered density of pre-synaptic markers including tyrosine hydroxylase, dopamine transporter; post-synaptic markers including dopamine receptors and phosphorylation of downstream targets including dopamine and cyclic-AMP regulated phosphoprotein of 32 kDa and cyclic-AMP-response element binding protein in different parts of the striatum. Ivermectin, an allosteric modulator of P2X4Rs, significantly affected dopamine and cyclic AMP regulated phosphoprotein of 32 kDa and extracellular regulated kinase1/2 phosphorylation in the striatum. Sensorimotor gating deficits in P2X4R KO mice were rescued by DA antagonists. Using the 6-hydroxydopamine model of DA depletion, P2X4R KO mice exhibited an attenuated levodopa (L-DOPA)-induced motor behavior, whereas ivermectin enhanced this behavior. Collectively, these findings identified an important role for P2X4Rs in maintaining DA homeostasis and illustrate how this association is important for CNS functions including motor control and sensorimotor gating. We propose that P2X4 receptors (P2X4Rs) regulate dopamine (DA) homeostasis and associated behaviors. Pre-synaptic and post-synaptic DA markers were significantly altered in the dorsal and ventral striatum of P2X4R KO mice, implicating altered DA neurotransmission. Sensorimotor gating deficits in P2X4R KO mice were rescued by DA antagonists. Ivermectin (IVM), a positive modulator of P2X4Rs, enhanced levodopa (L-DOPA)-induced motor behavior. These studies highlight potential interactions between P2X4Rs and DA system.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  6-OHDA; Ivermectin; P2X4 receptors; Parkinson's disease; dopamine receptors; schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 27402173      PMCID: PMC5037001          DOI: 10.1111/jnc.13734

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  79 in total

1.  Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons.

Authors:  S Hugel; R Schlichter
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Identification of the promoter region of the P2RX4 gene.

Authors:  Ben J Gu; Chun Sun; Valentina A Valova; Kristen K Skarratt; James S Wiley
Journal:  Mol Biol Rep       Date:  2009-12-02       Impact factor: 2.316

3.  Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach.

Authors:  Christoph Völter; Michael Riedel; Nicola Wöstmann; Désirée S Aichert; Sarah Lobo; Anna Costa; Anne Schmechtig; David A Collier; Annette M Hartmann; Ina Giegling; Hans-Jürgen Möller; Boris B Quednow; Dan Rujescu; Veena Kumari; Ulrich Ettinger
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-16       Impact factor: 5.176

4.  GABAA receptor alpha 1 and beta 2 subunit null mutant mice: behavioral responses to ethanol.

Authors:  Y A Blednov; D Walker; H Alva; K Creech; G Findlay; R A Harris
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

5.  Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.

Authors:  T V Lipina; M Niwa; H Jaaro-Peled; P J Fletcher; P Seeman; A Sawa; J C Roder
Journal:  Genes Brain Behav       Date:  2010-08-12       Impact factor: 3.449

Review 6.  The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.

Authors:  R K Schwarting; J P Huston
Journal:  Prog Neurobiol       Date:  1996-10       Impact factor: 11.685

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

8.  Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin.

Authors:  Irena Jelínkova; Vojtech Vávra; Marie Jindrichova; Tomas Obsil; Hana W Zemkova; Hana Zemkova; Stanko S Stojilkovic
Journal:  Pflugers Arch       Date:  2008-04-22       Impact factor: 3.657

9.  Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors.

Authors:  Maya Popova; James Trudell; Kaixun Li; Ronald Alkana; Daryl Davies; Liana Asatryan
Journal:  Purinergic Signal       Date:  2013-07-02       Impact factor: 3.765

10.  Preliminary evidence of striatal D2 receptor density as a possible biological marker of prognosis in naive schizophrenic patients.

Authors:  Víctor Pérez; Ana M Catafau; Iluminada Corripio; Juan Carlos Martín; Enric Alvarez
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-08       Impact factor: 5.067

View more
  20 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders.

Authors:  Alexia Duveau; Eléonore Bertin; Eric Boué-Grabot
Journal:  Neurosci Bull       Date:  2020-09-05       Impact factor: 5.203

Review 3.  Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin.

Authors:  I-Shan Chen; Yoshihiro Kubo
Journal:  J Physiol       Date:  2017-11-09       Impact factor: 5.182

Review 4.  Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders.

Authors:  Sheraz Khoja; Nhat Huynh; Alicia M P Warnecke; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  Psychopharmacology (Berl)       Date:  2018-03-02       Impact factor: 4.530

Review 5.  The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.

Authors:  Reece Andrew Sophocleous; Lezanne Ooi; Ronald Sluyter
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

6.  Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice.

Authors:  Sheraz Khoja; Nhat Huynh; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  Alcohol       Date:  2017-09-30       Impact factor: 2.405

Review 7.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

Review 8.  Contribution of P2X4 receptor in pain associated with rheumatoid arthritis: a review.

Authors:  Nurul Ajilah Mohamed Khir; Ain' Sabreena Mohd Noh; Nazlahshaniza Shafin; Che Aishah Nazariah Ismail
Journal:  Purinergic Signal       Date:  2021-02-17       Impact factor: 3.765

Review 9.  P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.

Authors:  Leanne Stokes; Janice A Layhadi; Lucka Bibic; Kshitija Dhuna; Samuel J Fountain
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

10.  Relationship between P2XR4 Gene Variants and the Risk of Schizophrenia in South-East of Iran: A Preliminary Case-Control Study and in Silico Analysis.

Authors:  Milad Heidari Nia; Mahdieh Jafari Shahroudi; Ramin Saravani; Saman Sargazi; Mahdiyeh Moudi; Azizollah Mojahed
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.